Cargando…
Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs
SIMPLE SUMMARY: Many countries have implemented, or are implementing, general age-based screening programs to reduce mortality due to colorectal cancer. Fecal hemoglobin immunodetection (FIT) in combination with endoscopy has already been relatively successful in achieving this goal. However, there...
Autores principales: | De Chiara, Loretta, Barcia-Castro, Leticia, Gallardo-Gómez, María, Páez de la Cadena, María, Martínez-Zorzano, Vicenta S., Rodríguez-Berrocal, Francisco J., Bujanda, Luis, Etxart, Ane, Castells, Antoni, Balaguer, Francesc, Jover, Rodrigo, Cubiella, Joaquín, Cordero, Oscar J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559671/ https://www.ncbi.nlm.nih.gov/pubmed/36230486 http://dx.doi.org/10.3390/cancers14194563 |
Ejemplares similares
-
A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples
por: Gallardo-Gómez, María, et al.
Publicado: (2018) -
Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas
por: Gallardo-Gómez, María, et al.
Publicado: (2023) -
Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer
por: Otero-Estévez, Olalla, et al.
Publicado: (2016) -
Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26(+) cancer stem cells subsets
por: Vázquez-Iglesias, Lorena, et al.
Publicado: (2019) -
Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test
por: Otero-Estévez, O, et al.
Publicado: (2015)